• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

老年人群戊型肝炎疫苗免疫策略的卫生经济学评价

Health economic evaluation of immunization strategies of hepatitis E vaccine for elderly population.

作者信息

Cheng Xiaoqing, Zhao Yueyuan, Zhang Xuefeng, Jin Hui, Min Jie

机构信息

a Department of Epidemiology and Health Statistics , School of Public Health, Southeast University , Nanjing , China.

b Key Laboratory of Environmental Medicine Engineering , Ministry of Education, School of Public Health, Southeast University , Nanjing , China.

出版信息

Hum Vaccin Immunother. 2017 Aug 3;13(8):1873-1878. doi: 10.1080/21645515.2017.1316913. Epub 2017 Apr 27.

DOI:10.1080/21645515.2017.1316913
PMID:28448739
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5557228/
Abstract

Objective This study was conducted to assess the cost-effectiveness of hepatitis E vaccination of elderly population in the sporadic regions in China. Methods We used a decision tree-Markov model to evaluate the cost-effectiveness of 3 kinds of hepatitis E virus vaccination strategies from societal perspectives. Parameter estimates were obtained from published researches and experts' opinion. The time horizon was 16 years, and the discounted rate was 3% annually. Costs are expressed in 2016 US dollars. Results The universal vaccination strategy had an incremental cost-effectiveness ratio (ICER) of US$ 8475.90 per QALY gained versus no vaccination. The implementation of screening and vaccination strategy would have an ICER of US$ 4044.28, compared with no vaccination. The vaccination was cost-effective (ICER< 3 times China's per capital gross domestic product/quality-adjusted life years). The QALY of asymptomatic infection, vaccine coverage and vaccine protection are the important parameters impacting the ICER in one-way sensitivity analysis and screening and vaccination being the dominant strategy in probabilistic sensitivity analysis. Conclusion This analysis indicates that screening and vaccination is the most cost-effective hepatitis E intervention strategy of elderly population in sporadic region in China.

摘要

目的 本研究旨在评估中国散发病区老年人群戊型肝炎疫苗接种的成本效益。方法 我们采用决策树-马尔可夫模型从社会角度评估3种戊型肝炎病毒疫苗接种策略的成本效益。参数估计值来自已发表的研究和专家意见。时间跨度为16年,年贴现率为3%。成本以2016年美元表示。结果 与未接种疫苗相比,普遍接种策略每获得一个质量调整生命年(QALY)的增量成本效益比(ICER)为8475.90美元。与未接种疫苗相比,实施筛查和接种策略的ICER为4044.28美元。接种疫苗具有成本效益(ICER<3倍中国人均国内生产总值/质量调整生命年)。在单向敏感性分析中,无症状感染的QALY、疫苗接种覆盖率和疫苗保护是影响ICER的重要参数,在概率敏感性分析中,筛查和接种是主导策略。结论 该分析表明,筛查和接种是中国散发病区老年人群最具成本效益 的戊型肝炎干预策略。

相似文献

1
Health economic evaluation of immunization strategies of hepatitis E vaccine for elderly population.老年人群戊型肝炎疫苗免疫策略的卫生经济学评价
Hum Vaccin Immunother. 2017 Aug 3;13(8):1873-1878. doi: 10.1080/21645515.2017.1316913. Epub 2017 Apr 27.
2
[Use the Markov-decision tree model to optimize vaccination strategies of hepatitis E among women aged 15 to 49].[使用马尔可夫决策树模型优化15至49岁女性戊型肝炎疫苗接种策略]
Zhonghua Liu Xing Bing Xue Za Zhi. 2017 Feb 10;38(2):267-271. doi: 10.3760/cma.j.issn.0254-6450.2017.02.026.
3
A preliminary cost-effectiveness analysis of hepatitis E vaccination among pregnant women in epidemic regions.流行地区孕妇戊型肝炎疫苗接种的初步成本效益分析。
Hum Vaccin Immunother. 2016 Aug 2;12(8):2003-2009. doi: 10.1080/21645515.2016.1141844. Epub 2016 Feb 22.
4
Economic evaluation of a publicly funded hepatitis A travel vaccination program in Ontario, Canada.加拿大安大略省一项基于公共资金的甲型肝炎旅行疫苗接种计划的经济评价。
Vaccine. 2019 Mar 7;37(11):1467-1475. doi: 10.1016/j.vaccine.2019.01.070. Epub 2019 Feb 13.
5
Cost-effectiveness analysis of a hepatitis B vaccination catch-up program among children in Shandong Province, China.中国山东省儿童乙型肝炎疫苗补种项目的成本效益分析
Hum Vaccin Immunother. 2014;10(10):2983-91. doi: 10.4161/hv.29944.
6
Targeted hepatitis E vaccination for women of childbearing age is cost-effective in China.对育龄妇女进行靶向性戊型肝炎疫苗接种在中国具有成本效益。
Vaccine. 2019 Sep 16;37(39):5868-5876. doi: 10.1016/j.vaccine.2019.08.003. Epub 2019 Aug 20.
7
Cost-effectiveness of screening and vaccinating Asian and Pacific Islander adults for hepatitis B.对亚太岛民成年人进行乙型肝炎筛查和疫苗接种的成本效益分析。
Ann Intern Med. 2007 Oct 2;147(7):460-9. doi: 10.7326/0003-4819-147-7-200710020-00004.
8
Probabilistic cost-effectiveness analysis of the long-term effect of universal hepatitis B vaccination: an experience from Taiwan with high hepatitis B virus infection and Hepatitis B e Antigen positive prevalence.乙肝疫苗普遍接种长期效果的概率性成本效益分析:来自台湾地区乙肝病毒高感染率和乙肝e抗原高阳性率的经验。
Vaccine. 2009 Nov 12;27(48):6770-6. doi: 10.1016/j.vaccine.2009.08.082. Epub 2009 Sep 5.
9
Cost-effectiveness of hepatitis A vaccination in Indonesia.在印度尼西亚,甲型肝炎疫苗接种的成本效益。
Hum Vaccin Immunother. 2014;10(8):2342-9. doi: 10.4161/hv.29353.
10
Health economic analysis of human papillomavirus vaccines in women of Chile: perspective of the health care payer using a Markov model.智利女性人乳头瘤病毒疫苗的健康经济分析:基于马尔可夫模型的医疗保健支付方视角
BMC Public Health. 2014 Nov 26;14:1222. doi: 10.1186/1471-2458-14-1222.

引用本文的文献

1
Cost-Effectiveness Analysis of Hepatitis E Vaccination Strategies for Swine Workers.养猪工人戊型肝炎疫苗接种策略的成本效益分析
Transbound Emerg Dis. 2025 Mar 10;2025:9371055. doi: 10.1155/tbed/9371055. eCollection 2025.
2
Evaluating the economic viability of hepatitis E virus serological screening among blood donors: A prospective study from India for advancing blood safety.评估献血者中戊型肝炎病毒血清学筛查的经济可行性:一项来自印度的前瞻性研究,以推进血液安全。
Asian J Transfus Sci. 2024 Jul-Dec;18(2):242-247. doi: 10.4103/ajts.ajts_33_24. Epub 2024 Dec 21.
3
Cost-Effectiveness of Hepatitis E Vaccination Strategies among Patients with Chronic Liver Diseases in China: A Model-Based Evaluation.中国慢性肝病患者中戊型肝炎疫苗接种策略的成本效益:基于模型的评估
Vaccines (Basel). 2024 Sep 26;12(10):1101. doi: 10.3390/vaccines12101101.
4
[Vaccines against hepatitis E virus: state of development].[戊型肝炎病毒疫苗:研发进展]
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2022 Feb;65(2):192-201. doi: 10.1007/s00103-022-03487-1. Epub 2022 Jan 31.
5
Cost Effectiveness of Meningococcal Serogroup B Vaccination in College-Aged Young Adults.脑膜炎 B 型球菌疫苗在大学年龄段青年中的成本效益。
Am J Prev Med. 2019 Feb;56(2):196-204. doi: 10.1016/j.amepre.2018.09.020. Epub 2018 Dec 17.
6
Assessing the value of screening tools: reviewing the challenges and opportunities of cost-effectiveness analysis.评估筛查工具的价值:审视成本效益分析的挑战与机遇。
Public Health Rev. 2018 Jul 13;39:17. doi: 10.1186/s40985-018-0093-8. eCollection 2018.

本文引用的文献

1
Cost-effectiveness of a herpes zoster vaccination program among the French elderly people.法国老年人中带状疱疹疫苗接种计划的成本效益
Hum Vaccin Immunother. 2016 Sep;12(9):2378-82. doi: 10.1080/21645515.2016.1184801. Epub 2016 Aug 2.
2
Cost-effectiveness of an influenza vaccination program offering intramuscular and intradermal vaccines versus intramuscular vaccine alone for elderly.为老年人提供肌肉注射和皮内注射疫苗与仅提供肌肉注射疫苗的流感疫苗接种计划的成本效益。
Vaccine. 2016 May 11;34(22):2469-76. doi: 10.1016/j.vaccine.2016.04.008. Epub 2016 Apr 11.
3
Consensus proposals for classification of the family Hepeviridae.嗜肝病毒科分类的共识建议。
J Gen Virol. 2015 May;96(Pt 5):1191-1192. doi: 10.1099/vir.0.000115.
4
Seroprevalence and risk factors of hepatitis E virus infection among children in China.中国儿童中戊型肝炎病毒感染的血清流行率和危险因素。
J Med Virol. 2015 Sep;87(9):1573-7. doi: 10.1002/jmv.24203. Epub 2015 May 4.
5
[Analysis on morbidity and mortality of viral hepatitis in China, 2004-2013].[2004 - 2013年中国病毒性肝炎发病率及死亡率分析]
Zhonghua Liu Xing Bing Xue Za Zhi. 2015 Feb;36(2):144-7.
6
Long-term efficacy of a hepatitis E vaccine.戊型肝炎疫苗的长期疗效。
N Engl J Med. 2015 Mar 5;372(10):914-22. doi: 10.1056/NEJMoa1406011.
7
Making hepatitis E a vaccine-preventable disease.将戊型肝炎变为可通过疫苗预防的疾病。
N Engl J Med. 2015 Mar 5;372(10):899-901. doi: 10.1056/NEJMp1415240.
8
The development of a recombinant hepatitis E vaccine HEV 239.重组戊型肝炎疫苗HEV 239的研发
Hum Vaccin Immunother. 2015;11(4):908-14. doi: 10.1080/21645515.2015.1008870.
9
Cost-effectiveness of hepatitis A vaccination in Indonesia.在印度尼西亚,甲型肝炎疫苗接种的成本效益。
Hum Vaccin Immunother. 2014;10(8):2342-9. doi: 10.4161/hv.29353.
10
Epidemiology of hepatitis E virus in China: results from the Third National Viral Hepatitis Prevalence Survey, 2005-2006.中国戊型肝炎病毒流行病学:2005 - 2006年第三次全国病毒性肝炎流行状况调查结果
PLoS One. 2014 Oct 31;9(10):e110837. doi: 10.1371/journal.pone.0110837. eCollection 2014.